Padilla, Baby Boy .
HRN: 26-94-97 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/21/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
04/21/2025
04/27/2025
IV
17mg
Q24
Tc Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes